Manufacturer copay assistance · Trazimera (Q5116) · Pfizer
Eligible commercially… · Maximum benefit Up to $25,000 per calendar year for out-of-pocket costs including co-pays or coinsurance · Covers Trazimera drug cost only — administration billed separately; applies to outpatient-administered claims only
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Trazimera — check the full fund board.
Run a benefits estimate for Trazimera — the program's cap applies against the patient share CareCost calculates.
Yes — Pfizer Oncology Together Co-Pay Savings Program for Injectables (Trazimera) from Pfizer. Eligible commercially insured patients may pay as little as $0 per Trazimera treatment. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible commercially insured patients may pay as little as $0 per Trazimera treatment Maximum benefit: Up to $25,000 per calendar year for out-of-pocket costs including co-pays or coinsurance. Covers Trazimera drug cost only — administration billed separately; applies to outpatient-administered claims only
Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, government.